Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients

Journal of Surgical Oncology

Volumn 106, Issue 2, 2012, Pages 162-168

  Chen, Yong ^a,b,c   Yang, Yun ^c   Wang, Chunmeng ^a,b   Shi, Yingqiang ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

adjuvant Chemotherapy; DSS; MFS; synovial sarcoma; TTM

Indexed keywords

DACARBAZINE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; MESNA;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CHILD; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; JOINT SURGERY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SYNOVIAL SARCOMA;

ADULT; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; EXTREMITIES; FEMALE; HUMANS; IFOSFAMIDE; KAPLAN-MEIER ESTIMATE; MALE; MESNA; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TAXOIDS;

EID: 84863717017     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23061     Document Type: Article

References (31)

1. Spillane AJ, A'Hern R, Judson IR, et al.: Synovial sarcoma: A clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000; 18: 3794-3803.
2. Eilber FC, Eilber FR,: Soft tissue sarcoma. In:, Cameron J, editor. Current surgical therapy. 7th edition. St. Louis: Mosby; 2001. pp. 1213-1218.
3. Ladanyi M, Antonescu CR, Leung DH, et al.: Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: A multi-institutional retrospective study of 243 patients. Cancer Res 2002; 62: 135-140. (Pubitemid 34073997)
4. Sun Y, Sun BC, Wang J, et al.: Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma. Cancer Sci 2009; 100: 1018-1025.
5. Trassard M, Le Doussal V, Hacene K, et al.: Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients. J Clin Oncol 2001; 19: 525-534. (Pubitemid 32112867)
6. Lewis JJ, Antonescu CR, Leung DHY, et al.: Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000; 18: 2087-2094. (Pubitemid 30324362)
7. Greene FL, Page D, Norrow M,: American Joint Committee on Cancer, American Cancer Society. AJCC Cancer staging handbook: From the AJCC cancer staging manual. 7th edition. New York: Springer; 2010.
8. Scurr M, Judson I,: Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas. Hematol Oncol Clin North Am 2005; 19: 489-500. (Pubitemid 40797886)
9. Kraybill WG, Harris J, Spiro IJ, et al.: Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 2006; 24: 619-625. (Pubitemid 46630425)
10. Tunn PU, Gebauer B, Fritzmann J, et al.: Soft tissue sarcoma. Chirurg 2004; 75: 1165-1173.
11. Casali PG, Jost L, Sleijfer S, et al.: Soft tissue sarcomas: ESMO clinical follow-up. Ann Oncol 2008; 19: ii89-ii93.
12. Soft tissue sarcoma. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. V2.2011.
13. Singer S, Brennan M,: Soft tissue sarcomas and bone tumors. In:, Townsend CM, Beauchamp DR, Evers BM, Mattox KL, editors. Sabiston textbook of surgery: The biological basis of modern surgical practice. 17th edition. Philadelphia: Elsevier; 2004. pp. 803-829.
14. Eilber FC, Brennan MF, Frederick RE, et al.: Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 2007; 246: 105-113. (Pubitemid 47012214)
15. Trojani M, Contesso G, Coindre JM, et al.: Soft-tissue sarcoma of adults: Study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37-42. (Pubitemid 14223231)
16. Sobin LH, Wittekind C,: Tumours of bone and soft tissues. TNM Classification of malignant tumours. New York: Wiley-Liss; 2002.
17. SMAC. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Lancet 1997; 350: 1647-1654.
18. Brodowicz T, Schwameis E, Widder J, et al.: Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: A prospective randomized feasibility trial. Sarcoma 2000; 4: 151-160. (Pubitemid 32055721)
19. Gortzak E, Azzarelli A, Buesa J, et al.: A randomized phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 2001; 37: 1096-1103.
20. Frustaci S, Gherlinzoni F, DePaoli A, et al.: Adjuvant chemotherapy for adult soft tissue sarcoma of the extremity and girdles: Results of the Italian randomized cooperative trial. J Clin Oncol 2001; 19: 1238-1247. (Pubitemid 32202526)
21. Grobmyer SR, Maki RG, Demetri GD, et al.: Neo-adjuvant chemotherapy for primary high grade extremity soft tissue sarcoma. Ann Oncol 2004; 15: 1667-1672. (Pubitemid 39562608)
22. Ferrari A, Gronchi A, Casanova M, et al.: Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004; 101: 627-634. (Pubitemid 38970615)
23. Edmonson JH, Ryan LM, Blum RH, et al.: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993; 11: 1269-1275. (Pubitemid 23199129)
24. Blay JO, Ray-Coquard I, Fayette J, et al.: Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: A retrospective analysis. Int J Cancer 2006; 119: 706-711. (Pubitemid 43955727)
25. Fredrik M, Ulf S, Anders R, et al.: Prognostic significance of chromosome aberrations in high-grade soft tissue sarcomas. J Clin Oncol 2008; 24: 315-320.
26. Jean MC, Philippe T, Louis G, et al.: Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. Cancer 2001; 91: 1914-1926.
27. DeLaney TF, Spiro IJ, Suit HD, et al.: Neoadjuvant chemotherapy and radiotherapy for large extremity soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2003; 56: 1117-1127. (Pubitemid 36794046)
28. Pisters PW, Leung DH, Woodruff J, et al.: Analysis of prognostic factors in 1.041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-1689. (Pubitemid 26134227)
29. Stojadinovic A, Leung DH, Hoos A, et al.: Analysis of the prognostic significance of microscopic margins in 2.084 localized primary adult soft tissue sarcomas. Ann Surg 2002; 235: 424-434. (Pubitemid 34183894)
30. Gronchi A, Lo Vullo S, Colombo C, et al.: Extremity soft tissue sarcoma in a series of patients treated at a single institution: Local control directly impacts survival. Ann Surg 2010; 251: 506-511.
31. Stojadinovic A, Leung DH, Allen P, et al.: Primary adult soft tissue sarcoma: Time-dependent influence of prognostic variables. J Clin Oncol 2002; 20: 4344-4352. (Pubitemid 35266296)